tiprankstipranks
Aurinia Pharmaceuticals (AUPH)
:AUPH
US Market

Aurinia Pharmaceuticals (AUPH) Income Statement

Compare
2,018 Followers

Aurinia Pharmaceuticals Income Statement

Last quarter (Q3 2024), Aurinia Pharmaceuticals's total revenue was $67.77M, an increase of 24.32% from the same quarter last year. In Q3, Aurinia Pharmaceuticals's net income was $14.35M. See Aurinia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 175.51M$ 134.03M$ 45.60M$ 50.12M$ 318.00K
Gross Profit
$ 161.37M$ 128.37M$ 44.51M$ -209.00K$ -52.55M
Operating Expenses
$ 253.06M$ 239.84M$ 225.25M$ 147.60M$ 76.57M
Depreciation and Amortization
$ 11.65M$ 2.71M$ 2.76M$ 1.37M$ 1.17M
EBITDA
$ -63.05M$ -103.65M$ -177.44M$ -102.92M$ -89.77M
Operating Income
$ -91.69M$ -111.47M$ -180.74M$ -104.29M$ -82.54M
Other Income/Expenses
$ 14.22M$ 5.12M$ 529.00K$ 1.52M$ 2.70M
Pretax Income
$ -77.47M$ -106.35M$ -180.21M$ -102.77M$ -123.70M
Net Income
$ -78.02M$ -108.18M$ -180.97M$ -102.68M$ -123.85M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.54$ -0.76$ -1.40$ -0.87$ -1.33
Diluted EPS
$ -0.54$ -0.76$ -1.40$ -0.87$ -1.33
Weighted Average Shares Outstanding
143.24M 141.91M 129.37M 118.47M 93.02M
Weighted Average Shares Outstanding (Diluted)
143.24M 141.91M 129.37M 118.47M 93.02M
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis